![Cancers | Free Full-Text | Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation Cancers | Free Full-Text | Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation](https://www.mdpi.com/cancers/cancers-15-03156/article_deploy/html/images/cancers-15-03156-g001-550.jpg)
Cancers | Free Full-Text | Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation
![Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of](https://ars.els-cdn.com/content/image/1-s2.0-S0959804914008727-gr3.jpg)
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
![Cancers | Free Full-Text | Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men Cancers | Free Full-Text | Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men](https://www.mdpi.com/cancers/cancers-14-04822/article_deploy/html/images/cancers-14-04822-g001.png)
Cancers | Free Full-Text | Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
![562 Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester | International Journal of Gynecologic Cancer 562 Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A251.2/F3.large.jpg)
562 Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester | International Journal of Gynecologic Cancer
![PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer | Anticancer Research PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/42/3/1547/F3.large.jpg)
PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer | Anticancer Research
![Survival rate in patients with ICU-acquired infections and its related factors in Iran's hospitals | BMC Public Health | Full Text Survival rate in patients with ICU-acquired infections and its related factors in Iran's hospitals | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12889-021-10857-y/MediaObjects/12889_2021_10857_Fig1_HTML.png)
Survival rate in patients with ICU-acquired infections and its related factors in Iran's hospitals | BMC Public Health | Full Text
![Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States](https://static.hindawi.com/articles/omcl/volume-2021/9999529/figures/9999529.fig.002f.jpg)
Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States
![Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer | Scientific Reports Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-16422-w/MediaObjects/41598_2022_16422_Fig1_HTML.png)
Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer | Scientific Reports
![Patrick Forde on X: "What about overall survival? This is the gold standard we look for when we treat pts with potentially curable cancer. It is early days (1st interim analysis) but Patrick Forde on X: "What about overall survival? This is the gold standard we look for when we treat pts with potentially curable cancer. It is early days (1st interim analysis) but](https://pbs.twimg.com/media/FQFEr10XIAIVPuX.jpg)
Patrick Forde on X: "What about overall survival? This is the gold standard we look for when we treat pts with potentially curable cancer. It is early days (1st interim analysis) but
![Overall survival rate curve. Notes: Overall survival rate curve was... | Download Scientific Diagram Overall survival rate curve. Notes: Overall survival rate curve was... | Download Scientific Diagram](https://www.researchgate.net/publication/306247552/figure/fig2/AS:396056534765568@1471438644022/Overall-survival-rate-curve-Notes-Overall-survival-rate-curve-was-constructed-using-the.png)
Overall survival rate curve. Notes: Overall survival rate curve was... | Download Scientific Diagram
![Cureus | The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy | Article Cureus | The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy | Article](https://assets.cureus.com/uploads/figure/file/524947/article_river_de5a7b20856b11edb5ee4d49807223a0-Fig1.png)
Cureus | The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy | Article
![Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data](https://www.archivesofmedicalscience.com/f/pictures/99749_28bf0.jpg)
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
![A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/0fbe43e7-b69c-43d2-bff9-10ce650542f3/gr1.jpg)
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
![Frontiers | Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation Frontiers | Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation](https://www.frontiersin.org/files/MyHome%20Article%20Library/877107/877107_Thumb_400.jpg)
Frontiers | Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation
![Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/attachment/71691e58-7199-4c54-b26a-fcd5317e2915/gr1_lrg.jpg)
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
![Overall survival rate in all patients according to influencing factors... | Download Scientific Diagram Overall survival rate in all patients according to influencing factors... | Download Scientific Diagram](https://www.researchgate.net/publication/293045147/figure/fig4/AS:1086760872357894@1636115391934/Overall-survival-rate-in-all-patients-according-to-influencing-factors-derived-from-Cox.jpg)